Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Cash from Financing Activities (2020 - 2026)

Definitive Healthcare filings provide 6 years of Cash from Financing Activities readings, the most recent being -$3.9 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 70.74% to -$3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$150.8 million, a 165.71% decrease, with the full-year FY2025 number at -$150.8 million, down 165.71% from a year prior.
  • Cash from Financing Activities hit -$3.9 million in Q4 2025 for Definitive Healthcare, up from -$12.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $234.7 million in Q4 2021 to a low of -$109.7 million in Q1 2025.
  • Median Cash from Financing Activities over the past 5 years was -$6.4 million (2022), compared with a mean of $6.2 million.
  • Biggest five-year swings in Cash from Financing Activities: surged 8302.62% in 2021 and later plummeted 538.05% in 2025.
  • Definitive Healthcare's Cash from Financing Activities stood at $234.7 million in 2021, then tumbled by 104.03% to -$9.5 million in 2022, then soared by 35.9% to -$6.1 million in 2023, then tumbled by 120.52% to -$13.4 million in 2024, then surged by 70.74% to -$3.9 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$3.9 million (Q4 2025), -$12.5 million (Q3 2025), and -$24.7 million (Q2 2025) per Business Quant data.